Literature DB >> 11879592

Uninvestigated Dyspepsia.

Uri Ladabaum1, William D. Chey.   

Abstract

Dyspepsia, which is defined as pain or discomfort centered in the upper abdomen, is encountered frequently in primary care and subspecialty practice. Dyspepsia is a symptom complex caused by a heterogeneous group of disorders and diseases. A large fraction of patients with dyspepsia suffer from functional dyspepsia, in which no evidence of organic disease (typically on the basis of upper endoscopy) is found to explain persistent or recurrent symptoms. Initial management strategies for uninvestigated dyspepsia include empiric antisecretory therapy, the "test-and-treat" strategy for Helicobacter pylori, or prompt upper endoscopy. The cost-effectiveness of empiric therapy versus the test-and-treat strategy is dependent upon a number of variables including the prevalence of H. pylori infection, ulcer prevalence, and likelihood that an ulcer is due to H. pylori infection. As the prevalence of H. pylori infection falls and the likelihood of H. pylori negative ulcer increases, empiric antisecretory therapy will become more cost-effective. Upper endoscopy should be reserved for patients older than 45 to 50 years with symptom presentation and those with warning signs. Endoscopy also should be considered in those for whom empiric therapy or an attempt at the test-and-treat strategy fails. Common-sense dietary counseling can be helpful in patients with meal-related symptoms. Highly restrictive diets rarely improve symptoms and may be counterproductive if nutrition is compromised.

Entities:  

Year:  2002        PMID: 11879592     DOI: 10.1007/s11938-002-0059-1

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  26 in total

1.  Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States.

Authors:  S Munnangi; A Sonnenberg
Journal:  Arch Intern Med       Date:  1997-07-14

2.  Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.

Authors:  L Laine; P Schoenfeld; M B Fennerty
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

3.  Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

Authors:  S Jyotheeswaran; A N Shah; H O Jin; G D Potter; F V Ona; W Y Chey
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

4.  Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

Authors:  P Moayyedi; R Feltbower; J Brown; S Mason; J Mason; J Nathan; I D Richards; A C Dowell; A T Axon
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

5.  A population-based serologic survey of Helicobacter pylori infection in children and adolescents in the United States.

Authors:  M A Staat; D Kruszon-Moran; G M McQuillan; R A Kaslow
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

6.  What makes the dyspeptic patient feel ill? A cross sectional survey of functional health status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice.

Authors:  A O Quartero; M W Post; M E Numans; R A de Melker; N J de Wit
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

7.  Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial.

Authors:  A T Lassen; F M Pedersen; P Bytzer; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

8.  Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.

Authors:  P G Farup; S Wetterhus; M Osnes; K Ulshagen
Journal:  Scand J Gastroenterol       Date:  1997-08       Impact factor: 2.423

Review 9.  Recent developments in the epidemiology of Helicobacter pylori.

Authors:  J E Everhart
Journal:  Gastroenterol Clin North Am       Date:  2000-09       Impact factor: 3.806

10.  Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.